Clinical trials: Neoplams, open to volunteers
Neoplams
Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant Tumors
A Phase 1, multiregional, open-label study of MST-168 in participants with target-driven advanced solid tumors. The goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics, immunogenicity…
- Trial name
- NCT07644650
- Testing
- MST-168
- Where
- China
- Volunteers
- 420 people
- Sponsor
- Mabsoft Therapeutics (Shanghai) Co., Ltd.
Prostatic Cancer, Prostatic Neoplams
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
Background: Prostate cancer is one of the most common cancers for men in the U.S. There are some new ways to take pictures of the cancer. There are also new ways to use image-guided biopsy and therapy.
- Conditions
- Prostatic Cancer, Prostatic Neoplams, Prostatic Hyperplasia, Prostate Cancer
- Trial name
- NCT03354416
- Where
- United States
- Volunteers
- 10,000 people
- Sponsor
- National Cancer Institute (NCI)
Malignant Neoplam, Advanced Solid Tumors
A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)
Researchers are looking for new ways to treat certain types of advanced solid tumors. Solid tumors are cancers mostly in organs and tissues in the body, not in the blood or other fluids.
- Trial name
- NCT07793942
- Testing
- MK-2010, Pembrolizumab, 5-Fluorouracil
- Where
- 6 sites in United States, Switzerland
- Volunteers
- 480 people
- Sponsor
- Merck Sharp & Dohme LLC
Cancer, Neoplams
Effect of Pecha Kucha-Based Education on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
This randomized controlled study aims to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy.
- Trial name
- NCT07769931
- Testing
- PechaKucha-Based Symptom Management Education, Routine/Standard Patient Education
- Where
- Turkey (Türkiye)
- Volunteers
- 140 people
- Sponsor
- Istanbul Aydın University
Non-communicable Diseases (NCD), Neoplams
Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data
The Health for Hungary (H4H) study collects blood samples and corresponding health data to investigate healthy aging and health-to-disease transitions in middle-aged and elderly participants.
- Conditions
- Non-communicable Diseases (NCD), Neoplams, Cancer, Lung Cancer (NSCLC)
- Trial name
- H4H (NCT07743021)
- Where
- 33 sites in Hungary
- Volunteers
- 15,000 people, healthy volunteers welcome
- Sponsor
- Center for Molecular Fingerprinting Research Nonprofit LLC
Neoplams, Physician-Patient Relations
One-Page Truth-Telling Aid for Cancer Disclosure
The goal of this clinical trial is to learn whether a one-page communication aid can improve communication between physicians and patients with cancer during cancer-related truth-telling consultations.
- Conditions
- Neoplams, Physician-Patient Relations, Communication Research, Disclosure
- Trial name
- NCT07730164
- Testing
- One-Page Truth-Telling Aid, Blank Sheet
- Where
- Taiwan
- Volunteers
- 400 people
- Sponsor
- Chang Gung University
Neoplams, Prostate Cancer (Adenocarcinoma)
Pilot Feasibility Study of a Dyadic Culinary Nutrition Intervention
This study will determine the feasibility and acceptability of a 12-week dyadic culinary nutrition program among Hispanic prostate cancer survivor/caregiver dyads using a randomized controlled trial design.
- Conditions
- Neoplams, Prostate Cancer (Adenocarcinoma), Cancer Survivors, Caregiver Burden
- Trial name
- CHEF (NCT07702864)
- Testing
- Cooking Healthy - Engaging Families (CHEF), Control
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Arizona
Cancer, Neoplams
xDRIVE for Florida-based Cancer Patients
Through this study funded by the Florida Cancer Innovation Fund, First Ascent will demonstrate state-wide feasibility of providing xDRIVE Functional Precision Medicine + Artificial Intelligence platform by assessing patient…
- Conditions
- Cancer, Neoplams, Refractory, Recurrence
- Trial name
- NCT07167381
- Testing
- xDRIVE Tumor Profiling
- Where
- 2 sites in United States
- Volunteers
- 210 people
- Sponsor
- First Ascent Biomedical Inc.
Neoplams
The Phase I Study of SIG001 Antibody on Cancer Therapy.
The goal of this clinical trial is to learn the safty characteristics of SIG001 Mab in cancer patients; It will also determine the Recommended Phase II dose of SIG001 Mab on cancer treatment, and pharmacological characteristics…
- Trial name
- NCT07486700
- Testing
- SIG001
- Where
- China
- Volunteers
- 66 people
- Sponsor
- Peking University
Neoplams, Patients
Plyometric Strength-Endurance Exercise in Breast Cancer
This study aims to compare an adapted plyometric strength-endurance exercise program with conventional strength training in women who are breast cancer survivors or currently undergoing treatment and who participate in provincial…
- Conditions
- Neoplams, Patients, Cancer Survivors
- Trial name
- NCT07460492
- Testing
- Plyometric Strength-Endurance Training, Conventional Strength Training
- Where
- Spain
- Volunteers
- 51 people
- Sponsor
- University of Vigo